Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2017-04-27 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20170427 - Notulen van de Algemene Vergadering 27 April 2017(signed).pdf
AGM Information Classification · 100% confidence The document is explicitly titled "GEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS GEHOUDEN OP DE MAATSCHAPPELIJKE ZETEL TE BRUSSEL OP DONDERDAG 27 APRIL 2017 OM 11 UUR # **NOTULEN**" (Minutes of the Ordinary General Meeting of Shareholders held on Thursday, April 27, 2017). The content details the composition of the bureau, verification of attendees, the agenda (including approval of annual accounts, remuneration report, director appointments, and long-term incentive plans), and the resulting resolutions. This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2017-04-27 Dutch
20170427 Press release re AGM-dividend (ENG).pdf
AGM Information Classification · 99% confidence The document explicitly states, 'UCB held its Annual General Meeting of Shareholders (AGM).' It details the outcomes of the meeting, including dividend approval, director re-appointments, and confirmation of the financial outlook. This content directly aligns with the description of 'AGM Information' (Code: AGM-R), which covers presentations and materials shared during the AGM. Although it mentions the Annual Report 2016 is available elsewhere, the primary focus and context of this specific document is the meeting itself and its resolutions.
2017-04-27 English
20170427 Press release re AGM-dividend (FR).pdf
AGM Information Classification · 99% confidence The document is titled 'Assemblée des actionnaires d'UCB' (UCB Shareholders' Meeting) and explicitly states that UCB held its 'assemblée générale annuelle' (Annual General Meeting - AGM). It details key outcomes of this meeting, such as the approval of the 2016 dividend (€ 1.15 per share), confirmation of 2017 financial forecasts, and the election/re-election of board members. This content directly corresponds to the definition of AGM Information.
2017-04-27 French
20170427 Press release re AGM-dividend (NL).pdf
AGM Information Classification · 99% confidence The document text is titled 'Algemene vergadering van aandeelhouders UCB' (General Meeting of Shareholders UCB) and explicitly discusses the proceedings, voting results ('Alle agendapunten voorgelegd ter stemming goedgekeurd'), dividend approval, and board reappointments that occurred during the Annual General Meeting (Algemene Vergadering). This directly corresponds to the definition of AGM Information.
2017-04-27 Dutch
20170407 - Acquisition of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled 'Acquisition of own shares' and details transactions where UCB SA/NV and its affiliates bought back UCB shares (52,055 and 83,122 shares) on specific dates (March 30, 2017, settlement April 3, 2017). This activity directly relates to the company purchasing its own stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS), which covers share repurchases. The document length is short (1783 chars), but it is the primary report of the transaction, not an announcement of a separate report, so RPA/RNS is not the primary fit.
2017-04-07 English
20170407 - Acquisition d'actions propres.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition d'actions propres" (Acquisition of own shares) and details transactions where UCB SA and its subsidiaries bought back UCB shares on March 30, 2017, for the purpose of employee compensation. This directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a specific regulatory announcement regarding share repurchase, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive transaction details.
2017-04-07 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.